ORV. Optimization or lobbying?
The influence of representatives of foreign companies on decisions of the Eurasian Economic Commission on the design of the legislation…
ARPM. A state support is important in orphan drug production
A conference on “Orphan deceases in adults” took place in the State Duma Committee on Healthcare. Participants from the different…
The effect of the “odd man out” decree on on the Russian pharmaceutical industry
The passing of the decree on “Introduction of limitations of allowance of foreign medicines to participate in state purchases” has…
ARPM welcomes the decision on the long awaited decree on the so-called “Odd man out”
The Government of Russian has approved a decree on “establishing limits to foreign drugs to access the public procurement” which…
Conference on Healthcare in Crimea
Despite the energetic blockage of the peninsula, a forum on “Healthcare in Crime- 2015. Regulation and Development” was successfully hold…
ARPM at the exhibition «Pharmtech & Ingredients”
The 17th International exhibition of medical equipment, substances and technologies for pharmaceutical production «Pharmtech & Ingredients 2015» took place in…
ARPM on insulin security of Russia
“In order to improve the system of drug provision for patients with diabetes mellitus it is important to increase competition…
ARPM on the current issues of preferential drug provision
“The system of preferential drug provision in Russia has been transformed several times in the past 15 years. The Government…
Pharmaceutical advertising is oriented for responsible self-medication
Advertisement of pharmaceutic in media was the main agenda of the talk organized by the State Duma committees on information…
ARPM at the conference Life Science Invest
The Fifth International Partnering- Forum «Life Sciences Invest. Partnering Russia» was held in St. Petersburg and brought together over 350…
- 1
- 2
- 3
- 4
- 5
- Go to the next page